Replies to post #188402 on Biotech Values

[DewDiligence]

AGTC—Informative webcast today at Roth conference:

http://www.wsw.com/webcast/roth29/#table3

No slides for the webcast per se, but AGTC’s latest slide set is in the SEC filing in #msg-111119164.

[DewDiligence]

AGTC inks AAV deal with (private) 4D Molecular Therapies:

http://finance.yahoo.com/news/agtc-4d-molecular-therapeutics-sign-110000790.html

Applied Genetic Technologies Corporation and 4D Molecular Therapeutics (4DMT)…today announced a collaboration and license agreement to discover and develop optimized AAV vectors to treat specific ophthalmic disease indications with high unmet medical need. As part of the agreement, 4DMT will deploy its proprietary AAV vector discovery platform, Directed Vector Evolution, to identify and optimize novel vectors. Financial details were not disclosed.

This deal is somewhat curious insofar as AGTC has claimed to have industry-leading expertise in AAV vectors; if that were true, why would they need 4DMT?

AGTC is down 2% today.

Comments welcome.